
1. nihon rinsho. 2004 jul;62(7):1363-7.

[proteasome inhibitor, bortezomib (vercade), potently inhibits growth of
adult t-cell leukemia cells].

[article japanese]

satou y(1), matsuoka m.

author information: 
(1)institute virus research, kyoto university.

the proteasome multicatalytic proteinase complex responsible the
degradation intracellular proteins, including crucial cell cycle
regulation, cell growth, apoptosis. bortezomib (vercade; formerly known as
ps-341) novel dipeptide boronic acid first proteasome inhibitor 
to progressed clinical trials. discuss mechanism of
bortezomib cancer therapy, review clinical data, introduce potent
effect atl cells.


pmid: 15283157  [indexed medline]

